Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin tear PK in healthy volunteers
NCT03252067Phase 1Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azithromycin in bacterial conjunctivitis (BC), sponsored by Beijing Tongren Hospital. Primary endpoints: Maximum Concentration at 24 hours and Area Under the Curve at 24 hours. Status: unknown.
02
Drugs
azithromycin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT03252067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03252067.